Research on the SARS-CoV-2 virus itself. Covers antiviral trials, antibody neutralization, viral escape, and rapid detection methods.
Researchers found that rare C-to-G mutations occurred at an unexpectedly high frequency during the emergence of the SARS-CoV-2 delta variant, contributing to its increased transmissibility. The study analyzed publicly available genome sequences and found that the delta lineage contained two C-to-G transversions in its spike protein.
Researchers at Bar-Ilan University and Weizmann Institute successfully engineered immune cells to recognize and attack cancer and viral targets. The enhanced T cells demonstrated stronger immune responses and greater cancer-killing ability, improving survival in mice.
Researchers at Gladstone Institutes have discovered how SARS-CoV-2 protein ORF8 hijacks immune cells to cause hyperinflammation, leading to severe lung damage. Blocking ORF8 reduces lung inflammation and damage in mice infected with SARS-CoV-2, offering a promising new path for developing treatments.
Researchers at ITQB NOVA discovered that SARS-CoV-2 has two fusion peptides in its spike protein, necessary for entering cells. The peptides work together to initiate membrane fusion, a crucial step for the virus's entry. Understanding this mechanism is crucial for developing strategies to block the virus.
A new study has found a significant link between Long COVID and POTS, with nearly two-thirds of Long COVID participants meeting the diagnostic criteria for POTS. The study suggests that POTS may be contributing to symptoms such as dizziness, fatigue, and brain fog in some individuals with Long COVID.
Researchers have characterized the structural and functional properties of the emerging SARS-CoV-2 sublineage RE.2.2, which displays enhanced binding to human ACE2 receptor and a novel N-linked glycosylation site. The study found that RE.2.2 has a distinct antibody escape profile and a remodeled immune evasion landscape.
A clinical trial funded by NIH found that PAXLOVID does not improve Long COVID symptoms, but its extended duration did not cause serious side effects. The study recruited 959 patients and monitored symptoms over six months.
A study maps how antibodies target a key region of the SARS-CoV-2 spike protein, neutralizing the virus, and how emerging variants escape. Researchers identified three immune escape strategies: disruption, glycan shielding, and conformational remodeling.
A novel LFIA based on selenium nanoparticles reveals long-term dynamics of neutralizing antibodies against SARS-CoV-2, showing accelerated antibody decline in patients with neurological and hematological diseases. The detection platform enables automated result readout and scalable monitoring for large populations.
An observational study found that early remdesivir treatment reduced the risk of all-cause graft loss and cardiovascular events in adult kidney transplant recipients with COVID-19. The study included 432 participants, with 177 receiving at least three days of remdesivir therapy.
A new study reveals that Republican lawmakers sponsored 86% of antivaccine bills introduced in state legislatures after the COVID-19 pandemic. Meanwhile, Democratic lawmakers supported provaccine bills, highlighting partisan polarization's impact on vaccine access and public health.
Researchers at Texas A&M University develop a laser technique called TRIP to directly measure quantum forces shaping proteins, enabling accurate prediction of how pharmaceutical drugs interact with them. This breakthrough could lead to the design of medicines tailored to specific diseases, revolutionizing precision medicine.
Researchers discovered a single amino acid change that allows coronaviruses to interact with human and bat immune systems differently, shifting the body's response to infection. This alteration enables benign animal viruses to adapt to humans and cause severe disease.
A study by Okayama University researchers revealed that SARS-CoV-2 antibody levels can assess infection history, symptom severity, and cognitive complications in long COVID. The findings suggest that declining S-antibody levels may indicate a greater risk of neurological complications.
A universal Sarbeco coronavirus vaccine has shown safety and no significant side effects in a human clinical trial, providing protection against multiple viruses, including SARS-CoV-2. The vaccine uses an AI-designed super-antigen to offer lasting protection against emerging virus threats.
A novel DNA aptamer, NP14, targets the N-terminal domain of the SARS-CoV-2 N protein for highly sensitive and mutation-resistant viral detection. A dual-mode biosensing platform combines visual and quantitative readouts to achieve ultrasensitive and reliable diagnosis.
Researchers found substantial declines in outpatient clinic visits (7%) and hospitalizations (13%) compared to expected levels. Long-term disruptions persist, with 65% of regions experiencing non-rebound outpatient visits and 74% with reduced hospitalizations.
A recent cohort study found that COVID-19 vaccination is associated with a lower risk of SARS-CoV-2 transmission. The study suggests that vaccination may indirectly reduce overall exposure to the virus.
Researchers at the University of Malaga propose a new antiviral strategy against SARS-CoV-2 by combining two complementary approaches that force viral instability and hinder adaptation. The dual-action treatment reduces viral load and alters genetic diversity, making it more difficult for the virus to survive.
Researchers used high-frequency ultrasound waves to eliminate viruses such as SARS-CoV-2 and H1N1 by causing structural changes that led to inactivation. The technique uses acoustic resonance, which differs from cavitation, a process used for decontamination.
Researchers discovered that early-stage ectoderm cells are especially susceptible to SARS-CoV-2 infection, with heightened vulnerability driven by elevated TMPRSS2 activity and thinner glycocalyx. This raises concerns about potential developmental risks, particularly for infants born to mothers infected during early pregnancy.
Researchers found no evidence of persistent SARS-CoV-2 in placentas collected from women who recovered from COVID-19. However, structural and inflammatory changes were observed in some placentas, suggesting the immune response may outlast the virus.
Researchers have found that COVID vaccines can train immune cells to remember the SARS-CoV-2 virus and protect against severe infection for years afterward. However, the continued spread of disease has scientists taking a closer look at how the immune system builds up immune memory over time.
Researchers observed nonrandom patterns of spike D614 reversions in SARS-CoV-2 delta and omicron BA.2 variants, suggesting a non-spontaneous mechanism. These reversions occurred disproportionately after peak transmission periods and showed geographic clustering.
Among highly boosted patients with cancer, overall postacute sequelae risk was not elevated compared to noninfected patients; hospitalized COVID-19 patients remained at increased risk despite therapeutics. Vaccination and boosting remain important in mitigating long COVID among immunocompromised patients
Researchers redesigned a key component of lipid nanoparticles to steer particles toward lymph nodes, reducing off-target delivery. This advancement could make mRNA vaccines more efficient, potentially achieving strong immune protection at lower doses.
Researchers at the University of Pennsylvania developed lipid nanoparticles that modify immune metabolism to strengthen mRNA vaccines and reduce common side effects. The new lipid boosts the metabolism of immune cells, providing energy for the body's defenses while dialing down inflammatory signals.
A new UC San Diego study challenges the idea that pandemic viruses require rare adaptations in animals to infect humans. The research found that most zoonotic viruses, including COVID-19, do not show evidence of prior adaptation before emerging in humans.
A randomized, double-blind clinical trial found that a natural fungal supplement, FoTv, reduced short-term vaccine side effects and helped antibodies last longer in people who had not previously been exposed to COVID-19. The study suggests that FoTv may help strengthen vaccine protection without increasing side effects.
A study from the University of East Anglia found that Covid lockdowns disrupted children's ability to self-regulate, leading to slower growth in executive functions. Reception-age children, who normally learn to socialize and navigate classroom routines, showed significant setbacks in cognitive flexibility and self-regulation skills.
The study found that the intranasal vaccine booster Clec9A OMNI induced significantly stronger neutralising antibody responses and robust T-cell responses in the lungs and nasal tissues, offering robust protection against SARS-CoV-2 Omicron infection. This breakthrough may address current shortcomings of COVID-19 mRNA vaccines, includi...
A recent study published in Science Translational Medicine found that infant immune systems respond very differently to RSV and SARS-CoV-2, with important treatment implications. Infants infected with RSV often develop severe symptoms due to low levels of systemic inflammation and a poorly coordinated early immune response.
A study from Linköping University in Sweden found no association between COVID-19 vaccination and decreased childbirth rates. Researchers analyzed data on over 60,000 women and found no statistically significant difference between vaccinated and unvaccinated groups.
The study found that 2024-2025 COVID-19 vaccines offer protection against COVID-19 hospitalization and severe in-hospital outcomes. Monitoring vaccine effectiveness remains crucial to guide vaccine composition and recommendations.
A new hypothesis article proposes that HPV E6 and SARS-CoV-2 spike proteins could cooperate in suppressing host defenses including tumor suppressor mechanisms involving p53. Laboratory studies suggest that combined viral pressures on tumor-suppressor pathways may contribute to cancer progression.
A new study reveals that COVID-19 vaccination influences long-term immunity, with those vaccinated first showing stronger antibody responses to Omicron variants. The study found higher levels of IgG and IgA antibodies in vaccinated individuals, but a stronger T-cell response in those infected first.
This study found that vaccination before and during COVID-19 diagnosis in pregnancy significantly lowers the risk of severe maternal illness and premature birth. The results suggest that COVID-19 vaccination plays a crucial role in protecting pregnant individuals from serious health complications associated with the virus.
Research by Politecnico di Milano finds that even a small percentage of individuals who don't follow health measures can significantly increase the infection peak and strain healthcare facilities. The study emphasizes the need to monitor and adapt public health strategies to individual urban contexts, making interventions more effective.
Researchers have identified promising compounds that can combat resistant COVID-19 variants by targeting an enzyme similar to one used by Chagas disease. Compounds 5a and 5b, synthesized from older chemical libraries, demonstrated strong Mpro inhibition with low toxicity.
Researchers discovered a 'sticky' molecule, P-selectin, that can cause blood clots and organ failure during COVID-19. A new mRNA therapy that drives P-selectin expression provides broad protection against coronavirus infection.
Researchers at EMBL-EBI developed SPRTA, an interpretable and efficient way to score the reliability of each branch in a phylogenetic tree. This method enables fast and reliable understanding of virus strain evolution, informing better decisions during outbreaks.
Patients with advanced lung and skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer. The vaccine was associated with a near doubling of median survival, from 20.6 months to 37.3 months in lung cancer patients.
Researchers argue that AI can strengthen pandemic preparedness by detecting emerging diseases earlier. By combining data from humans, animals, and the environment, AI can reveal patterns and provide insights into potential pathogens.
A new pediatric study found that young people infected with COVID twice are twice as likely to develop long COVID, with increased risks for heart disease, damaged kidneys, cognitive issues, and more. The study analyzed data from over 407,000 patients across 40 pediatric hospitals.
A cohort study investigated olfactory dysfunction in US adults with and without prior SARS-CoV-2 infection. The study found a significant association between prior infection and persistent olfactory dysfunction. High variability was observed among individuals, highlighting the need for individualized assessment and treatment strategies.
Researchers discovered that COVID-19 can persist in gastrointestinal tissue for up to six weeks after a positive nasal swab test, leading to increased inflammation and damage. The study highlights the need for monitoring patients with high levels of SERPINA1, who may be at risk for poor outcomes.
Scientists at Scripps Research have pinpointed dozens of human proteins that SARS-CoV-2 needs to complete its full life cycle. Two promising drug targets, perlecan and BIRC2, show potential in blocking coronaviruses at multiple stages of infection.
A clinical trial led by Professor Robert Bals found that azelastine nasal spray significantly reduced the risk of SARS-CoV-2 infection by 66%. The treatment group showed fewer symptomatic infections and lower respiratory rates compared to the placebo group.
The COVID-19 virus replicates using cellular machinery responsible for testosterone production, altering lipid metabolism and potentially leading to lower testosterone levels. This study reveals the mechanism by which SARS-CoV-2 targets testicular cells, offering insights into male vulnerability to COVID-19.
Patients with Long COVID are using digital tools and online communities to track symptoms, identify patterns, and develop care plans. Despite medical dismissiveness, self-tracking data helps patients advocate for diagnostic tests and treatment.
A comprehensive epidemiological study found that people who had COVID-19 are at increased risk of developing certain inflammatory diseases of the airways, such as asthma and chronic sinusitis. Vaccination against SARS-CoV-2 virus appears to reduce this risk.
A new study from UCLA finds that the definition of Long COVID varies widely across published studies, resulting in dramatically different estimated prevalence rates. The study highlights the need for a standardized definition to advance research and improve patient care.
Adults with long COVID experience worse work impairment, missed work, and financial distress compared to those without long COVID. Vaccination is associated with improved work outcomes and reduced financial distress among individuals with long COVID.
This book delves into the scientific foundations of mucosal vaccine platforms, discussing immunological mechanisms, novel adjuvants, and real-world development challenges. It serves as a valuable resource for professionals and students in life sciences, immunology, and pharmacology.
A synthetic glycosystem mimics natural sugars on human cells, binding to virus's spike protein and preventing infection. The molecule was found to be effective at low doses and worked against multiple SARS-CoV-2 strains.
A multi-year clinical research study in US children documents the rebound of endemic respiratory viruses after the COVID-19 pandemic. The study shows that non-pharmaceutical interventions decreased circulation rates of common respiratory pathogens in children, enabling more accurate predictions for future outbreaks.
Scientists have identified a previously unknown virus in Pacific oysters linked to annual mass die-offs, highlighting the importance of disease prevention measures. The discovery also underscores the need for further research into the causes of mortality in oyster populations.
Researchers at Chan Zuckerberg Biohub San Francisco and Stanford University have developed an AI-driven Virtual Lab that can tackle sophisticated scientific problems. The team of AI agents, each equipped with varied expertise, can formulate, refine, and carry out complex research strategies, producing results that can be validated in r...
Researchers at Stanford Medicine have developed a virtual lab powered by AI, allowing them to tackle complex biological problems and devise innovative solutions. The virtual lab has been successfully tested in devising a new basis for a vaccine against recent COVID-19 variants using nanobodies.
A new UNLV-led study uses AI to detect emerging virus variants in wastewater samples, outperforming existing methods. The algorithm can identify unique signatures for different virus variants with as few as two to five samples, significantly earlier than current methods.